​

Capstone Holding Stock (NASDAQ:CAPS)

RevenueFinancialsChart
Capstone Holding by TradingView

Previous Close

$1.05

52W Range

$0.96 - $16.18

50D Avg

$1.22

200D Avg

$1.91

Market Cap

$5.84M

Avg Vol (3M)

$2.50M

Beta

-0.81

Div Yield

-

CAPS Company Profile

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.

Show More

Industry

Construction Materials

Sector

Basic Materials

Exchange

NASDAQ

ADR

-

Country

US

Employees

36

IPO Date

Jan 28, 1993

Website

CAPS Performance

CAPS Financial Summary

Dec 24Dec 23Dec 22
Revenue$44.88M$48.35M$61.56M
Operating Income$-638.00K$-1.26M$3.99M
Net Income$-2.56M$-3.82M$2.31M
EBITDA$-121.00K$-1.75M$4.23M
Basic EPS$-34.86$-36.39$14.69
Diluted EPS$-34.86$-36.39$14.69

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

TickerCompany
RETOReTo Eco-Solutions, Inc.
ENFYEnlightify Inc.
GUREGulf Resources, Inc.
NITON2OFF, Inc.
RKDAArcadia Biosciences, Inc.
INHDInno Holdings Inc. Common Stock
CNEYCN Energy Group. Inc.